Precision Therapies in IgA Nephropathy Management
Precision therapies are revolutionizing IgA nephropathy (IgAN) management by targeting specific disease pathways, offering hope to those affected by this chronic kidney condition. As FDA-approved drugs like modified-release budesonide and sparsentan highlight therapy advancements, integrating lifestyle changes and understanding proteinuria’s role remain critical. Explore how precision medicine transforms traditional approaches to enhance patient care. Understanding […]